Goodwin on Medtech

Goodwin partners attended the Houston MedTech Rodeo in March 2026, leading strategic discussions in sessions covering venture/M&A strategy and the importance of life cycle medtech legal counsel for medtech companies.

Goodwin’s Rare Disease Initiative convened for its Rare Disease Executive Roundtable and Networking Reception in Boston on February 5, 2026. This private event brought together senior executives and visionaries across biotech, patient advocacy, investing, and policy for candid discussions and community building.

Goodwin and KPMG hosted their 7th Annual Symposium @ JP Morgan on January 14, 2026, to share strategic insights on how industry leaders are leveraging dealmaking to advance pipelines, strengthen balance sheets, and position for long-term success.

Medtech partners attended the annual Goodwin Rare Disease Symposium in Boston on February 5. The program featured a range of voices and perspectives from the rare disease community.

Members of the Medtech practice attended the 43rd JPM Healthcare Conference in San Francisco, CA. Goodwin and KPMG hosted the 6th Annual Symposium @ JP Morgan on January 15, 2025. At the symposium, we delved into strategies that enable life sciences companies to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital from growth.